Medfinder
Back to blog

Updated: March 11, 2026

Edarbi Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Edarbi Shortage Update: What Patients Need to Know in 2026

Is Edarbi in shortage in 2026? Get the latest update on Edarbi availability, why it's hard to find, current costs, and what patients can do right now.

Edarbi Shortage Update: What Patients Need to Know in 2026

If you take Edarbi (Azilsartan Medoxomil) for high blood pressure and you've been struggling to fill your prescription, you're probably wondering: is there an Edarbi shortage? What's going on with the supply? And what are your options right now?

Here's the latest on Edarbi availability in 2026 — and what you can do to keep your blood pressure treatment on track.

Is Edarbi Still in Shortage?

As of early 2026, Edarbi is not officially listed on the FDA's drug shortage database. That means there is no formal shortage reported by the manufacturer or the FDA.

However, that doesn't tell the whole story. Many patients continue to report difficulty finding Edarbi at their local pharmacies. The disconnect between "no official shortage" and "I can't find it anywhere" comes down to how pharmacies stock medications — and Edarbi's unique position as a brand-name drug without a generic.

Why Is Edarbi Hard to Find?

Even without an official shortage, several factors make Edarbi difficult to locate:

No Generic Version Available

Edarbi remains a brand-name-only medication. While the FDA approved a generic application (ANDA) for Azilsartan Medoxomil in 2022, patent protections have kept generic manufacturers from bringing a product to market. Without a generic option, pharmacies depend entirely on the single brand-name supply from Azurity Pharmaceuticals.

Low Pharmacy Demand

Most patients with high blood pressure are prescribed widely available generic ARBs like Losartan, Valsartan, or Olmesartan. Because Edarbi prescriptions are less common, many pharmacies — especially large chains — don't keep it in their regular inventory. They may need to special order it, which adds time and inconvenience.

Insurance Step Therapy

Many insurance plans require patients to try cheaper alternatives before approving Edarbi. This step therapy requirement reduces the number of Edarbi prescriptions filled, which in turn reduces the incentive for pharmacies to stock it.

Supply Chain Factors

Broader pharmaceutical supply chain challenges — from manufacturing to distribution — can cause regional variations in availability. A pharmacy in one city might have Edarbi in stock while another pharmacy 50 miles away does not.

For a deeper explanation, see our article on why Edarbi is so hard to find.

How Much Does Edarbi Cost in 2026?

Cost is a significant factor for many Edarbi patients. Here's what you can expect to pay:

  • Cash price (no insurance): $294 to $376 per month for 30 tablets of 80 mg
  • With manufacturer copay card: As low as $15 per month for commercially insured patients (through the Azurity Solutions E-Z Rx Program)
  • With discount cards (GoodRx, SingleCare): Varies by pharmacy, but may offer some savings off the retail cash price

Compare that to generic ARB alternatives:

  • Generic Losartan: $4 to $15 per month
  • Generic Valsartan: $10 to $20 per month
  • Generic Olmesartan: $10 to $25 per month

For full details on saving money, read our guide on how to save money on Edarbi.

Are There New Options for Blood Pressure Treatment?

The ARB drug class has been well-established for decades, and no new ARBs have entered the market recently. However, there are a few developments worth noting:

  • Combination therapies — Edarbyclor (Azilsartan Medoxomil/Chlorthalidone) combines Edarbi with a diuretic in a single tablet. If your doctor wants you on both an ARB and a diuretic, this may be an option.
  • Generic ARB availability — The generic ARB market is robust, with affordable options like Losartan, Valsartan, Olmesartan, and Telmisartan widely available
  • Telehealth prescribing — Getting an Edarbi prescription or discussing alternatives is now easier through telehealth platforms, which can connect you with a doctor without an in-person visit

For a comparison of alternatives, see our article on alternatives to Edarbi.

How to Find Edarbi in Stock

If you want to stay on Edarbi, here are the most effective strategies for finding it:

1. Use Medfinder

Medfinder lets you search for pharmacies near you that have Edarbi in stock. It's the fastest way to skip the phone-call runaround and get your prescription filled.

2. Check Independent Pharmacies

Independent and specialty pharmacies are more flexible about ordering brand-name medications. If the big chains don't have Edarbi, a local independent pharmacy may be able to get it for you within 1 to 2 business days.

3. Ask for a Special Order

Your pharmacist can often order Edarbi directly from their wholesaler. Just ask — many patients don't realize this is an option.

4. Request a 90-Day Supply

A 90-day prescription means fewer refills and less frequent hunting for the medication. Ask your doctor about writing a 90-day script.

5. Consider Mail-Order Pharmacy

Mail-order pharmacies may carry Edarbi and can ship it directly to your home, eliminating the in-person search entirely.

For a complete guide, see how to find Edarbi in stock near you.

Final Thoughts

Edarbi isn't in a formal shortage, but real-world availability remains a challenge for many patients in 2026. The lack of a generic alternative, low pharmacy stocking, and insurance barriers all contribute to the difficulty.

The most important thing is to not let a supply issue interrupt your blood pressure treatment. Use tools like Medfinder to find Edarbi near you, explore savings programs to manage costs, and talk to your doctor about alternatives if needed. Staying proactive about your health is the best thing you can do.

Frequently Asked Questions

Edarbi is not currently listed on the FDA's official drug shortage database. However, many patients still have difficulty finding it at local pharmacies because it is a brand-name-only medication with low stocking rates. Using tools like Medfinder can help you locate pharmacies that have it available.

The FDA approved a generic application for Azilsartan Medoxomil in 2022, but patent protections have prevented generic manufacturers from bringing it to market. There is no confirmed date for when a generic will become available for purchase at pharmacies.

Without insurance, Edarbi costs approximately $294 to $376 per month for a 30-day supply of 80 mg tablets. With the manufacturer's Azurity Solutions E-Z Rx copay card, commercially insured patients may pay as little as $15 per month.

Try using Medfinder to find another pharmacy with Edarbi in stock, check with independent pharmacies that may be able to special order it, or talk to your doctor about temporarily switching to a generic ARB like Losartan or Olmesartan until Edarbi is available.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

32,326 have already found their meds with Medfinder.

Start your search today.

32K+
5-star ratingTrusted by 32,326 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?